BACKGROUND: Systemic sclerosis (scleroderma) is a life-threatening autoimmune disease that is characterized by the presence of specific autoantibodies and fibrosis of the skin and major internal organs. METHODS: We genotyped a polymorphism (G-945C) in the promoter of the connective-tissue growth factor (CTGF) gene in 1000 subjects in two groups: group 1, consisting of 200 patients with systemic sclerosis and 188 control subjects; and group 2, consisting of 300 patients with systemic sclerosis and 312 control subjects. The combined groups represented an estimated 10% of patients with systemic sclerosis in the United Kingdom. We tested the effect of the polymorphism on the transcription of CTGF. RESULTS: The GG genotype was significantly more common in patients with systemic sclerosis than in control subjects in both groups, with an odds ratio for the combined group of 2.2 (95% confidence interval [CI], 1.5 to 3.2; P<0.001 for trend). Analysis of the combined group of patients with systemic sclerosis showed a significant association between homozygosity for the G allele and the presence of anti-topoisomerase I antibodies (odds ratio, 3.3; 95% CI, 2.0 to 5.6; P<0.001) and fibrosing alveolitis (odds ratio, 3.1; 95% CI, 1.9 to 5.0; P<0.001). We observed that the substitution of cytosine for guanine created a binding site of the transcriptional regulators Sp1 and Sp3. The C allele has high affinity for Sp3 and is associated with severely reduced transcriptional activity. A chromatin immunoprecipitation assay showed a marked shift in the ratio of Sp1 to Sp3 binding at this region, demonstrating functional relevance in vivo. CONCLUSIONS: The G-945C substitution represses CTGF transcription, and the -945G allele is significantly associated with susceptibility to systemic sclerosis.
Fonseca, C., Lindahl, G.E., Ponticos, M., Sestini, P., Renzoni, E.A., Holmes, A.M., et al. (2007). A polymorphism in the CTGF promoter region associated with systemic sclerosis. NEW ENGLAND JOURNAL OF MEDICINE, 357(12), 1210-1220.
|Titolo:||A polymorphism in the CTGF promoter region associated with systemic sclerosis.|
|Citazione:||Fonseca, C., Lindahl, G.E., Ponticos, M., Sestini, P., Renzoni, E.A., Holmes, A.M., et al. (2007). A polymorphism in the CTGF promoter region associated with systemic sclerosis. NEW ENGLAND JOURNAL OF MEDICINE, 357(12), 1210-1220.|
|Appare nelle tipologie:||1.1 Articolo in rivista|